{"url_path":"/sec/gctk/8-k/2026-05-15/item-3-01","section_key":"item-3-01","section_title":"Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1506983/0001493152-26-023889-index.html","accession_number":"0001493152-26-023889","cik":"0001506983","ticker":"GCTK","issuer_name":"Glucotrack, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1506983/0001493152-26-023889-index.html","primary_entity_key":"0001506983","primary_entity_name":"Glucotrack, Inc."},"word_count":621,"has_tables":true,"body_markdown":"**Item\n3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.**\n\n \n\nAs\npreviously disclosed, on May 11, 2026, Glucotrack, Inc. (the “Company”) received a Staff Determination letter (the “Staff\nDetermination”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the\nCompany that it no longer complied with Rule 5550(a)(2) of Nasdaq’s Listing Rules which requires listed securities to maintain\na minimum bid price of $1.00 per share (the “Bid Price Rule”), and that the Nasdaq staff (the “Nasdaq Staff”)\nhad determined to delist the Company’s securities from The Nasdaq Capital Market. The Company intends to timely request a hearing\nbefore a Nasdaq Hearings Panel (the “Panel”) by May 18, 2026, to appeal Nasdaq Staff’s determination. A timely hearing\nrequest will stay any further delisting actions through the hearing process. At the hearing, the Company expects to present its plan\nto regain compliance with the Bid Price Rule.\n\n \n\nOn\nMay 15, 2026, the Company received a second letter from Nasdaq notifying the Company that its Form 10-Q for the period ended March\n31, 2026, indicates that the Company no longer meets the $2,500,000 minimum stockholders’ equity requirement for continued\nlisting set forth under Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Requirement”), and the Company\ndoes not meet the alternatives of market value of listed securities or net income from continuing operations. Accordingly, the\nfailure to comply with the Minimum Stockholders’ Equity Requirement has become an additional basis for delisting. The Nasdaq\nStaff further notified the Company that failure to meet the Minimum Stockholders’ Equity Requirement will be considered in its\ndecision regarding the Company’s continued listing on The Nasdaq Capital Market. The Company intends to present its views with\nrespect to this additional deficiency to the Panel at its hearing. There can be no assurance that the Company will be successful in\nits appeal, that the Panel will grant the Company’s request for continued listing, or that the Company will be able to regain\nor maintain compliance with any applicable Nasdaq listing requirements.\n\n \n\n**Forward-Looking\nStatements**\n\n \n\nThis\nCurrent Report on Form 8-K contains “forward-looking statements” within the meaning of the Private Securities Litigation\nReform Act of 1995. Forward-looking statements can be identified by words such as “projects,” “may,” “will,”\n“could,” “would,” “should,” “believes,” “expects,” “anticipates,”\n“estimates,” “intends,” “plans,” “potential,” “promise” or similar references\nto future periods. Examples of forward-looking statements in this Current Report on Form 8-K include, without limitation, statements\nregarding the Company’s intent or ability to regain compliance with the Bid Price Rule and the Minimum Stockholders’ Equity\nRequirement, the outcome of the Nasdaq hearing and appeal process, and the ability for the common stock to remain listed on Nasdaq. Any\nforward-looking statements in this Current Report on Form 8-K are based on management’s current expectations of future events and\nare subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set\nforth in or implied by such forward-looking statements. For a discussion of these and other risks and uncertainties, and other important\nfactors, any of which could cause the Company’s actual results to differ from those contained in or implied by the forward-looking\nstatements, see the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended\nDecember 31, 2025 filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 30, 2026, as well as discussions\nof potential risks, uncertainties and other important factors in any subsequent Company filings with the SEC. All information in this\nCurrent Report on Form 8-K is as of the date of the filing; the Company undertakes no duty to update this information unless required\nby law."}